CARGO Therapeutics, Inc. (CRGX) Stock Statistics & Valuation Metrics

CARGO Therapeutics, Inc. has a market cap or net worth of $210.46M. The enterprise value is $503.14M.

CARGO Therapeutics, Inc. has 46,052,370 shares outstanding. The number of shares has decreased by -2.65% in one year.

CARGO Therapeutics, Inc.’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -48.09%.

The current PE Ratio of CARGO Therapeutics, Inc. is -3.87. CARGO Therapeutics, Inc.’s PEG ratio is -0.07.

In the last 12 months, CARGO Therapeutics, Inc. had revenue of 0.00 and earned -167.50M in profits. Earnings per share was -3.72.

In the last 12 months, operating cash flow was -139.74M and capital expenditures -4.45M, giving a free cash flow of -144.19M billion.

CARGO Therapeutics, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

CARGO Therapeutics, Inc. upcoming earnings date is Nov 12, 2024, TBA Not Confirmed.

CARGO Therapeutics, Inc. as a current ratio of 13.79, with Debt / Equity ratio of 8.17%

In the past 12 months, CARGO Therapeutics, Inc. has paid 0.00 in taxes.

CARGO Therapeutics, Inc. EV to EBITDA ratio is -3.27, with an EV/FCF ratio of -4.25.

CARGO Therapeutics, Inc. has $339.70M in cash and marketable securities with $29.43M in debt, giving a net cash position of -$310.28M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for CARGO Therapeutics, Inc. is $4.00, which is 11.43% higher than the current price. The consensus rating is Hold